Finerenone and effects on mortality in chronic kidney disease and type 2 diabetes: a FIDELITY analysis.

European heart journal. Cardiovascular pharmacotherapy(2023)

引用 9|浏览47
暂无评分
摘要
FIDELIO-DKD and FIGARO-DKD are registered with ClinicalTrials.gov, numbers NCT02540993 and NCT02545049, respectively (funded by Bayer AG).
更多
查看译文
关键词
All-cause mortality,Cardiovascular mortality,Chronic kidney disease,Finerenone,Non-steroidal MRA,Type 2 diabetes
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要